Zhong B H, Deng R X, Shi Y L, Li G F, Zhong J X, Yang J D, Wang J
Institute of Microbiology and Epidemiology, Academy of Military Medical Science, Beijing.
Yao Xue Xue Bao. 1994;29(4):268-75.
On basis of our previous work, seven 4-methyl-5-substituted phenoxy-6-methoxy-8-(1-methyl-4-amino-butylamino)-quinolines (II2-8) were synthesized and their antimalarial activities were preliminarily evaluated. The target compounds were prepared from 2-nitro-4-methoxy-5-bromo-acetanilide as previously described. The structures of II2-8 and all of the unknown intermediates were confirmed by elementary and spectral analyses. Preliminary biological evaluation revealed that all of II2-8 exhibited significant blood schizonticidal activity and were 4-8 times as effective as primaquine in causal prophylactic test in mice.
基于我们之前的工作,合成了七种4-甲基-5-取代苯氧基-6-甲氧基-8-(1-甲基-4-氨基丁基氨基)喹啉(II2-8),并对其抗疟活性进行了初步评价。目标化合物如前所述由2-硝基-4-甲氧基-5-溴乙酰苯胺制备。通过元素分析和光谱分析确定了II2-8以及所有未知中间体的结构。初步生物学评价显示,所有II2-8均表现出显著的血裂殖体杀灭活性,在小鼠病因性预防试验中,其效果是伯氨喹的4至8倍。